Biotech Startups

Interpace Biosciences provides molecular diagnostic tests for the early diagnosis and treatment of cancer, with a focus on risk-stratifying indeterminate thyroid nodules through genetic and mutational analysis. The company serves specialty physicians and medical centers in the U.S. and internationally.

2 investors

Intrommune is a biotechnology company developing oral mucosal immunotherapy (OMIT), which delivers allergenic proteins through a specially formulated toothpaste to treat peanut and other food allergies. Its products target patients and families managing food allergies, spanning early allergen introduction in at-risk children and treatment options for those living with food allergy.

2 investors

Intron Biotechnology is a South Korean biotech company developing novel drugs based on bacteriophage platform technology, including "First-in-Class" treatments for multidrug-resistant superbacteria and "First-in-Concept" therapeutics targeting microbiome, viruses, and immune modulation. It positions itself as a global R&BD group in the biopharmaceutical field.

2 investors

Invenra develops proprietary platform technologies to discover and develop novel bi- and multi-specific antibody therapies, with an initial focus on oncology. The company is advancing pipelines of antibody candidates with partners and intends to expand into additional disease categories.

2 investors

Invitris develops cell-free protein synthesis platforms that enable rapid design, expression, and scalable production of complex proteins for biopharmaceuticals, industrial biotechnology, and agriculture.

2 investors

InvVax is developing a universal influenza vaccine based on its own vaccine technology. The company focuses on biotechnology and vaccine research and commercialization.

2 investors

iollo develops Quinn, an AI system for computational R&D in life sciences that automates data coding, analysis, and interpretation from target discovery through clinical trials. It also offers a consumer metabolomics test panel that measures markers related to energy production, inflammation, and cellular aging.

2 investors

Iolyx is a pharmaceutical company focused on developing treatments for ocular conditions. The company assembles a team of experienced scientists, clinicians, and regulatory experts in drug development and ophthalmology.

2 investors

iOmx Therapeutics is a biotech company developing novel cancer therapies. Based in Munich's Martinsried biotech hub, the company focuses on transforming cancer treatment through scientific research and collaborative innovation.

2 investors

IONLACE develops modular protein design tools, combining AI models with a lab-in-the-loop experimental approach to design and engineer new molecules for medicine. The company builds biotech tools aimed at advancing human health and programmable biology.

2 investors

A clinical-stage biotech company developing novel targeted cancer therapies and immunomodulatory drugs with a global equity strategy. The company operates a translational medicine platform and focuses on solid tumors and drug-resistant cancers.

2 investors

ionSIGHT provides an AI-driven analytical platform using native mass spectrometry to analyze protein structure and interactions for drug discovery applications. The platform enables high-throughput structural biology and biophysics insights for pharmaceutical developers.

2 investors

iosBio develops oral, thermostable vaccine candidates using its ESD platform, with a lead program (OraPro-EBV) targeting Epstein-Barr Virus. The company operates in the biotechnology and vaccine development sector.

2 investors

Iovance develops TIL (tumor-infiltrating lymphocyte) therapy, a personalized cancer treatment that isolates immune cells from a patient's tumor, expands them in a centralized facility using proprietary manufacturing processes, and returns them for infusion back into the patient.

2 investors

IQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.

2 investors

iRiva Medical is a development-stage medical device company building neuromodulation technology platforms to treat patients with chronic diseases. A NuXcel spinoff based in Minneapolis, it develops implantable neuromodulation therapies targeting large patient populations with unmet clinical needs.

2 investors

ISOThrive is a clinical-stage biotech company developing proprietary digestion-resistant carbohydrates that target specific bacteria to correct microbiome dysbiosis, aimed at treating chronic diseases linked to microbiome imbalance. Its lead asset, ISOT-101 (maltosyl-isomaltooligosaccharide/MIMO), is in a phase 2 study.

2 investors

Jade Biosciences develops therapeutic antibodies targeting autoimmune diseases, with a lead candidate in clinical development for immunoglobulin A nephropathy, a chronic kidney disease. The company's pipeline includes additional candidates designed to modulate immune system responses in autoimmune conditions.

2 investors

Javara is a clinical research organization that partners with healthcare organizations to integrate clinical trials into patient care, providing patients with access to investigative therapies and delivering patient and data services for biopharma and research organizations.

2 investors

Jointechlabs develops point-of-care regenerative medicine devices and therapies that process a patient's own adipose tissue into microfat and stromal vascular fraction for use in joint pain, orthopedics, sports medicine, aesthetics, and wound healing. Its products and pipeline, aimed at healthcare professionals and their patients, include medical devices, biologic drugs, and 3D bioprinting approaches for conditions such as osteoarthritis and chronic wounds.

2 investors

Juniper Genomics provides genomic testing for IVF, including enhanced PGT-A that analyzes both DNA and RNA from a single embryo biopsy to assess chromosome status and embryo viability, and PGT-G that expands analysis across nearly the full genome from the same sample. Its products serve fertility clinicians and IVF patients making embryo selection and genetic risk decisions.

2 investors

Jupiter is a biotech company that discovers and develops new medicines across multiple therapeutic areas. The company is led by a team of experienced scientists and executives with a track record of creating approved drugs and founding successful biotech companies.

2 investors

Kadance provides insurance-based precision health programs and clinical navigation services focused on addressing health inequities through genomics-informed care. The company serves insurers and their members, particularly in oncology care and cancer survivorship management.

2 investors

Kanaphterapeutics is a pharmaceutical company developing synthetic drugs and antibody-based therapeutics for cancer treatment using proprietary human genome analysis and ADC (antibody-drug conjugate) technologies.

2 investors